Fact CheckerSign in

NCT06028503Recruiting

ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community

Effectiveness of a Community-Based Intervention of Acceptance and Commitment Therapy for Type 2 Diabetes Management in a Rural and Underserved Community

Source: ClinicalTrials.gov · Last updated 15 May 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this project is to examine the feasibility/acceptability of a one-day Acceptance and Commitment Therapy + Lifestyle Education group intervention paired with 12-weeks of Continuous Glucose Monitoring for patients with type 2 diabetes (T2D) living in rural communities. This study is being designed as a randomized control trial (RCT) comparing ACT+LE+CGM to LE+CGM to LE. The ultimate goal of this line of research is that a community-wide intervention of Acceptance and Commitment Therapy (ACT) with Continuous Glucose Monitoring (CGM) and Lifestyle Education (LE) will improve T2D outcomes in rural communities compared to CGM and LE, or LE alone. Our goal is to develop a scalable and sustainable program for diabetes management in rural areas that enables individual self-management and does not require extensive healthcare resources in an existing medical desert.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
31 Jul 2023
Start date
1 Apr 2024
Primary completion date
31 Aug 2026
Lead sponsor
Sam Houston State University
NCT number
NCT06028503

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 1 Apr 2024 to the primary completion date, 31 Aug 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Pregnant (management of diabetes while pregnant may require additional medical oversight).

Age

  • Under 18 years old (protocol was validated for adults)

Other

  • Reported suicidal ideation at the initial visit
  • has evidence of acute psychosis that precludes informed consent
  • appears to be cognitively impaired to the extent that precludes informed consent
  • uses a heavy amount of alcohol or other substances
  • is deemed by the multidisciplinary study team has too medically complex for a more conservative treatment approach
  • has a pacemaker or other implanted electrical medical device
  • Non-English-speaking individuals (protocol has not been translated and validated in other languages)

Who the study is looking for

  • Diagnosed diabetes (self-reported) and with an HbA1c ≥ 6.0 (using point-of-care device)
  • at least 18 years of age or older
  • able to speak English
  • able to provide informed consent and participate in the study
  • reliable access to a personal smartphone device 6) zip code is associated with a rural area.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sam Houston State University College of Osteopathic Medicine
Coordinator of this site? Confirm its status
ConroeUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.